NAGS 抗体 (C-Term)
Quick Overview for NAGS 抗体 (C-Term) (ABIN630135)
抗原
See all NAGS 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term
-
特异性
- NAGS antibody was raised against the C terminal of NAGS
-
纯化方法
- Purified
-
免疫原
- NAGS antibody was raised using the C terminal of NAGS corresponding to a region with amino acids YLDKFVVSSSRQGQGSGQMLWECLRRDLQTLFWRSRVTNPINPWYFKHSD
-
-
-
-
应用备注
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
NAGS Blocking Peptide, (ABIN936130), is also available for use as a blocking control in assays to test for specificity of this NAGS antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NAGS antibody in PBS
-
浓度
- Lot specific
-
缓冲液
- PBS
-
注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NAGS (N-Acetylglutamate Synthase (NAGS))
-
别名
- NAGS
-
背景
- NAGS is a mitochondrial enzyme that catalyzes the formation of N-acetylglutamate (NAG) from glutamate and acetyl coenzyme-A. NAG is a cofactor of carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle in mammals. Deficiencies in N-acetylglutamate synthase have been associated with hyperammonemia.
-
分子量
- 58 kDa (MW of target protein)
抗原
-